Ono Pharmaceutical Co. (OPHLF)
(Delayed Data from OTC)
$15.03 USD
0.00 (0.00%)
Updated Jul 24, 2024 10:49 AM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPHLF 15.03 0.00(0.00%)
Will OPHLF be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OPHLF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPHLF
Ono Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Why
New Strong Sell Stocks for June 2nd
OPHLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth Stock
Ono Pharmaceutical Co. (OPHLF) Upgraded to Strong Buy: What Does It Mean for the Stock?
Other News for OPHLF
Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript
Ono Pharmaceutical reports FY results